Introduction
============

Hip fractures are a global public health problem, occurring 1.6 million times worldwide in 1990, and their incidence is seeing an increasing trend in many countries across the globe partly due to an increase in the average life expectancy, and the increasing incidence of osteoporosis.[@b1-ppa-8-651],[@b2-ppa-8-651] After indicated surgical treatment, hip fracture patients experience high rates of morbidity, mortality, and disability, with approximately 5% dying during hospitalization and 10% dying within 30 days.[@b3-ppa-8-651],[@b4-ppa-8-651] These unfortunate outcomes are challenging for perioperative clinicians, including anesthesiologists.

The choice of anesthesia for this surgery is still an issue of continuing debate. Epidural anesthesia (EA), peripheral nerve blocks (PNBs), or general anesthesia (GA) are suitable for surgery in fragile patients. The first article on the assessment of anesthetic types was published in 1936.[@b5-ppa-8-651] Since then, there have been many trials, observational studies, reviews, meta-analyses, and systematic reviews focusing on this point.[@b6-ppa-8-651]--[@b8-ppa-8-651] In 2000, Rodgers et al showed that the use of neuraxial techniques can result in a decrease in mortality and several complications.[@b7-ppa-8-651] However, they were unable to draw conclusions on the validity of these findings to specific surgical procedures or patient populations. In addition, many of these studies are now approximately 20 years old. Thus, it has been difficult to draw conclusions regarding the effects of anesthesia choice on the outcomes for hip surgery.

With the development of ultrasonographic imaging and neurostimulation technology, more and more anesthesiologists have tended to select PNBs for lower limb surgery. PNB with propofol sedation is a sophisticated technique and is generally implemented in our hospital. This technique is not merely regional anesthesia or GA but a combination of the two, which administers sparing narcotic, propofol sedation with or without a oropharyngeal airway or laryngeal mask. Perioperative hemodynamic stability and improved postoperative analgesia make it more suitable for fragile patients with serious comorbidities.

In our department, anesthesiologists select the anesthesia style based on their preference and expertise, as well as the patients' general condition. For example, patients with cognitive dysfunction who can't communicate normally always receive GA, and those patients with respiratory malfunction receive PNBs preventing from mechanical ventilation and inhaled gas, which can damage the respiratory system.

We therefore decided to investigate a population with femoral neck fractures (FNF) undergoing hemiarthroplasty in our hospital, to compare the effectiveness of GA and PNBs for postoperative complications and mortality. Our primary outcome is mortality at in-hospital, 30-day, and 1-year postoperatively. The secondary outcomes are major postoperative complications. This retrospective study may focus on the investigation of anesthetic factors influencing mortality and postoperative complications in a cohort of Chinese patients in our hospital.

Materials and methods
=====================

Data source
-----------

We explored postoperative mortality and complications in elderly patients undergoing urgent hemiarthroplasty for FNF who received GA or PNBs at the Chinese People's Liberation Army General Hospital from January 2008 to December 2012. The electronic database includes discharge records for all patients treated in the hospital and contains information on patient demographics, preoperative comorbidities, postoperative complications, anesthetic type, and in-hospital mortality. Thirty-day and 1-year mortality after surgery were recorded by a telephone interview or mail.

To create the cohort of patients aged 65 years or more, we selected all discharges with a principal or secondary diagnosis code for FNF, including pathologic fractures and traumas. To restrict our sample, we excluded patients who were diagnosed with multiple traumas and those who underwent a secondary surgical procedure during their hospital stay. To eliminate the influence of the operation and anesthesia types, patients who had undergone internal fixation (n=39), total hip arthroplasty (n=68), or no surgery (n=28) were excluded, and patients who had received EA (n=113) were also excluded. Finally, the remaining 217 subjects for hemiarthroplasty who received GA or PNBs were completed and used for further analysis ([Figure 1](#f1-ppa-8-651){ref-type="fig"}).

Anesthesia management
---------------------

Patients who received GA were routinely induced with midazolam, sufentanil, etomidate, and rocuronium, followed by laryngeal mask airway insertion and mechanical ventilation. Anesthesia was maintained with remifentanil and propofol with 60% oxygen. Infusion rates of propofol and remifentanil varied according to clinical judgment.

PNBs procedure was described in detail in our previous study.[@b9-ppa-8-651] Briefly, midazolam and sufentanil were titrated to provide sufficient sedation before nerve block insertion. Supplemental oxygen (5 L/minute) was administered using a face mask. After sterile preparation and draping, the nerve blocks were administered using a 21-gauge, 100 mm nerve block needle (Stimuplex A^®^; B. Braun Melsungen AG, Melsungen, Germany) under nerve stimulator guidance. A posterior approach to lumbar plexus block was performed with patients in the lateral decubitus position. After a quadriceps muscle response had been identified with nerve stimulator settings at 2 Hz frequency and current at 0.3--0.5 mA, 20--30 mL of 0.30% ropivacaine was injected in divided doses. Sciatic nerve block was performed in the same position after a twitch of the hamstring, soleus, foot, or toes, had been elicited using a similar current, and 15--20 mL of 0.30% ropivacaine was injected. Sensory and motor blocks on the operated limb were evaluated until achievement of adequate nerve block to allow surgery. Sedation during surgery was provided by propofol with light sleep, ventilating spontaneously with a oropharynx parichnos or mechanically with a laryngeal mask. Supplemental analgesia with 5--10 μg sufentanil was administered if required.

Surgical intervention
---------------------

All the operations were performed by two orthopedic surgeons (PFT and QZ) experienced in the procedure using a modified Hardinge anterolateral approach, with the patients in the lateral decubitus position.[@b10-ppa-8-651] All patients were given low-molecular-weight heparin calcium (Fraxiparine^®^; GlaxoSmithKline, London, UK) preoperatively and for at least 10 days postoperatively, although this was interrupted from preoperative 1 day to 12 hours after surgery. Ceftriaxone-Na (Rocephin^®^; 1.0 g; F. Hoffmann-La Roche Ltd., Basel, Switzerland), was given 30 minutes preoperatively, followed by two additional doses during the first 72 hours.

Assessment and follow-up
------------------------

The primary outcome was in-hospital, 30-day, and 1-year mortality after surgery. The secondary outcomes are postoperative complications. The following general complications include: acute cardiovascular events, including myocardial infarction; acute respiratory events; stroke; delirium; electrolyte disturbances; hypoxemia; deep wound infection; and deep vein thrombosis/pulmonary embolus. We also examined the following data: waiting time to operation; duration of operation; postoperative hospital length of stay (PLOS); intensive care unit (ICU) admission; hospital charges; and blood loss and transfusion.

Statistical analysis
--------------------

For continuous parameters, Student's *t*-tests were used to test for differences between groups, and chi-square statistics were used to detect differences for discontinuous parameters, including in-hospital mortality. Univariate and multivariate Cox regression analysis of all variables were used for 30-day and 1-year mortality after surgery. The significance level for all statistical tests was set at 5% (*P*\<0.05). Data were coded and stored in Microsoft Excel (2007; Redmond, WA, USA) and analyzed with the statistical program SPSS (v17.0; IBM Corporation, Armonk, NY, USA).

Results
=======

Demographics
------------

During a 5-year period, 217 senior patients who had undergone hemiarthroplasty were eventually included in the analysis. The mean age was 79.8 years (range 65--103 years). Statistical analysis comparing patient characteristics between GA and PNBs groups is summarized in [Table 1](#t1-ppa-8-651){ref-type="table"} and no statistically significant findings were made. Most of the patients were female (151/217; 69.6%). The results for intraoperative fluid, PLOS, hospital charges, ICU admission, duration of operation, waiting time to operation, and blood loss and transfusion are presented in [Table 2](#t2-ppa-8-651){ref-type="table"}. There were no statistically significant differences between the two anesthetic techniques.

Mortality
---------

Mortality was 6.9%, 14.7%, and 23.5% at in-hospital, 30-day, and 1-year postoperatively, and no statistically significant differences were found between the two groups. In- hospital mortality was slightly lower in the GA group (9.7%, 7/72) when compared to the PNBs group (5.5%, 8/145). However, this did not reach statistical significance (*χ*^2^=1.32; *P*=0.250).

Postoperative complications
---------------------------

Sixty-eight patients (31.3%) had one postoperative complication; 51 (23.5%) had two, and 27 (14.3%) had three or more complications. [Table 3](#t3-ppa-8-651){ref-type="table"} shows the incidence of postoperative complications. The most common complications were acute cardiovascular events (55; 25.3%), electrolyte disturbances (51; 23.5%), and delirium (50; 23.0%). The incidence of acute respiratory events was higher in the GA group than in the PNBs group, although no statistical significance was found (*χ*^2^=0.68; *P*=0.410). Accordingly, there were similar tendencies for postoperative hypoxemia between the groups (*χ*^2^=3.416; *P*=0.065).

Preoperative comorbidities
--------------------------

In our study, only 54 patients (24.9%) had no preoperative comorbidity; 72 (33.2%) had one, 57 (26.3%) had two, and there were 34 (15.7%) patients with three or more comorbidities. [Table 3](#t3-ppa-8-651){ref-type="table"} lists the comorbidities recorded and their incidence between groups. The most common were cardiovascular diseases (69; 31.8%), respiratory system diseases (52; 24.0%), and diabetes (51; 23.5%). Dementia was more common in the GA group than in the PNBs group (*χ*^2^=10.45; *P*=0.001; [Table 3](#t3-ppa-8-651){ref-type="table"}).

Preoperative and postoperative risk factors for 30-day and 1-year mortality
---------------------------------------------------------------------------

[Table 4](#t4-ppa-8-651){ref-type="table"} shows univariate Cox regression analysis of all variables for mortality at 30 days and 1 year after surgery. [Table 5](#t5-ppa-8-651){ref-type="table"} shows the results of the multivariate Cox regression analysis. The mortality of postoperative acute cardiovascular events was 41.8% (23/55) at 30 days (hazard ratio \[HR\]: 8.8, 95% confidence interval \[CI\]: 5.0--18.9). The mortality at 1-year was 80.0% (44/55; HR: 6.0, 95% CI: 3.2--10.6). Of the patients who developed acute respiratory events, the mortality was 30.3% (10/33; HR: 8.5, 95% CI: 6.6--13.1) at 30 days and 54.5% (18/33; HR: 5.0, 95% CI: 3.5--7.3) at 1 year.

The HRs for patients with respiratory system diseases after adjustments for age and sex are as follows: at 30 days (HR: 2.4, 95% CI: 1.5--3.8), male (HR: 1.6, 95% CI: 1.2--2.1), and dementia (HR: 2.0, 95% CI: 1.5--3.7) ([Table 5](#t5-ppa-8-651){ref-type="table"}). Increasing age; male; American Society of Anesthesiologists (ASA) status; perioperative cardiovascular and respiratory events; postoperative stroke and hypoxia; three or more comorbidities; and postoperative complications were also key factors.

Discussion
==========

Our study has shown 6.9%, 14.7%, and 23.5% mortality at in-hospital, 30-day, and 1-year postoperatively in elderly patients who have undergone hemiarthroplasty for FNF. One hundred and fifty (69.1%) patients had one or more postoperative complications. The most common were acute cardiovascular events, electrolyte disturbances, and delirium. There were no statistically significant differences between the two groups. In-hospital mortality was slightly lower in the GA group (9.7%) when compared to the PNBs group (5.5%). However, this did not reach statistical difference. Preoperative parameters were not statistically significantly different except that patients who received GA were more likely to have dementia. Increasing age; male; ASA status; perioperative cardiovascular and respiratory events; postoperative stroke and hypoxia; having three or more comorbidities; and postoperative complications are all risk factors for postoperative mortality.

The mortality at 30 days and 1 year after surgery is similar to that found in previous studies[@b8-ppa-8-651],[@b11-ppa-8-651] and no statistically significant differences were found between the two anesthetic techniques. However, few studies have compared the outcomes between GA and PNBs in Chinese patients. Interestingly, male patients (14; 21.2%) have a significantly higher mortality at 30 days than female patients (18; 11.9%), who lived longer on average.[@b12-ppa-8-651] Our results showed high mortality for patients who developed acute cardiovascular and respiratory events. Within 30 days after surgery, 41.8% (23/55) of patients with acute cardiovascular events and 30.3% (10/33) with acute respiratory events died, whereas only 9.8% (5/51) of patients with electrolyte disturbances died. Forty-four (80.0%) patients with acute cardiovascular events died within 1 year postoperatively.

Some of our patients with hip fractures are from outside the immediate vicinity of our district. Perhaps these patients were sicker at baseline than others with hip fractures who remained at the local hospitals. It is possible that the patients were transferred to us because they were "too sick" and therefore had a higher risk of early mortality.

One hundred and sixty-three patients (75.1%) had one or more comorbidities on admission. The most common were cardiovascular diseases, respiratory system diseases, diabetes, and stroke. It appears that some patients with preoperative comorbidities did not have serious postoperative complications. Previous research has indicated that myocardial infarction, dementia, and respiratory system diseases result in a greater risk of postoperative complications and increased mortality.[@b13-ppa-8-651],[@b14-ppa-8-651] One in-hospital patient in the PNBs group had a myocardial infarction after surgery and died during their postoperative in-hospital stay, while a patient in the GA group suffered perioperative cardiac arrest and died in hospital, although both had been managed carefully and operated on successfully.

Thirty-three patients (15.2%) in our study had dementia; these patients are thought to be more likely to have postoperative complications and higher mortality.[@b15-ppa-8-651],[@b16-ppa-8-651] The incidence of dementia was much higher in the GA group (19/72; 26.4%) than in the PNBs group (14/145; 9.7%; *P*=0.001). "Mental deterioration in the elderly can be avoided by selecting regional rather than general anaesthesia."[@b16-ppa-8-651] Due to the importance of body posture during the PNBs procedure, many patients with dementia were not suited for this anesthetic type and had to receive GA in our data. Accordingly, lower mortality at in-hospital and 30-day postoperatively in the PNBs group could not be fully attributed to the anesthetic type.

The hypovolemia was poorly tolerated by the more fragile patients, even if the blood loss was less. A retrospective study of over 8,000 elderly patients with hip fractures found that perioperative transfusion had no influence on mortality in patients with hemoglobin concentrations \>80 g/L,[@b17-ppa-8-651] although some other studies have shown that transfusion at higher hemoglobin concentrations for patients with known cardiac disease may be beneficial.[@b18-ppa-8-651],[@b19-ppa-8-651] The issue of whether a blood transfusion should be administered is still inconclusive in this fragile population.

Meanwhile, "persistent hypoxia may be present in all patients with hip fractures from the time of admission until up to several days postoperatively."[@b20-ppa-8-651] In our study, 33 (15.2%) patients were hypoxemic when the first arterial blood samples were drawn; of these, 27 patients (81.8%) still had arterial oxygen pressure \<60 mmHg postoperation. Futhermore, anemia, hypoxemia, and hypoproteinemia invariably occur concomitantly, which may be positively correlated to postoperative mortality.[@b21-ppa-8-651],[@b22-ppa-8-651] As such, an appropriate transfusion threshold would limit risk and optimize benefits in the elderly. Therefore, in our department, all patients are continually administered supplemental oxygen (3--5 L/minute) with a nasal catheter perioperatively. We recommend that the hemoglobin concentrations \<90 g/L should be administered in fragile patients.

Electrolyte disturbances are common preoperation (23; 10.6%) and during the first 3 days postoperatively (51; 23.5%). Hypokalemia is the most common electrolyte abnormality and is intractable even if the patient is given potassium transvenously and via oral intake. Six patients (11.8%) with postoperative electrolyte disturbances died within 30 days after surgery, but positive correlation of these deaths has not been confirmed.

Hip fracture patients are at high risk of delirium, with incidence ranging from 35% to 50%.[@b6-ppa-8-651],[@b15-ppa-8-651],[@b16-ppa-8-651] Some evidence has indicated that improved postoperative analgesia with PNBs could decrease the incidence of delirium. Unfortunately, our retrospective data did not include analgesic outcomes. The incidence of delirium was 25% (18) in the GA group and 22.1% (32) in the PNBs group; this difference was not statistically significant in our study (*P*=0.629). However, the research demonstrates that risk of delirium in elderly patients prognosticates increasing PLOS and hospital charges.

The frequency of ICU admission in PNBs group is more than that in the GA group numerically (20% vs 12.5%; *P*=0.171). Contrary to what might have been expected, we show that ICU admission is not positively associated with increased mortality at the observed time points. However, patients with ICU admission have higher hospital charges and longer PLOS.

No significant differences were found between the groups in our study regarding blood loss (GA vs PNBs; 429±199 mL vs 422±197 mL; *P*=0.806) and blood transfusions. As in previous reports,[@b23-ppa-8-651] blood loss may attribute to intraoperative blood pressure and surgical time. Unfortunately, we did not analyze blood pressure in these groups due to the limited records.

In our study, the interval time from trauma to surgery was long and some surgeries were delayed for up to 7 days. Empirical evidence has demonstrated that shortening surgery delay reduces complications, PLOS, and mortality.[@b24-ppa-8-651]--[@b26-ppa-8-651] However, another study showed no significant difference in mortality between patients having early or delayed surgery.[@b27-ppa-8-651] Some sicker patients received earlier surgery, nevertheless they did not have adequate physiologic reserves and remained under resuscitation. Hence, delaying surgery to adequately resuscitate patients and optimizing medical conditions do not worsen the outcomes.

To the subpopulation with hip fracture which administered no anticoagulation, deep vein thrombosis may be less frequent duration of hospital stay in RA than that in GA.[@b28-ppa-8-651] In our department, all patients with lower limb surgery must be administered low-molecular-weight heparin, a prophylactic anticoagulant. We did not find a statistically significant difference in clinical thrombosis between the GA and PNBs groups (*P*=0.658).

Regarding PLOS and hospital charges, there were no statistically significant differences between the two groups (*P*=0.631 and *P*=0.601, respectively). The hospital charges, excluding procedural and equipment charges, are more dependent on the cost of presurgery comorbidities and postoperative complication care. However, the cost of hospitalization increased with a delay in surgery, PLOS, and ICU admission in our study.

With the development of anesthesiology and the theoretic improvement of anesthesiologists, anesthetic techniques are improving over time. In 2008, GA was applied in 45.7% of patients, and PNBs are applied in 14.3% of patients. By 2012, GA decreased to only 12.9%, where PNBs sharply increased to 52.7%. Furthermore, in 2008, patients weren't usually admitted to the ICU unless they presented serious complications, such as cardiac arrest, or acute cardiac or respiratory failure. Nowadays, our patients at high cardiac or respiratory risk are routinely admitted to the ICU during the first 1 or 2 days postoperatively. Thus, we did not observe higher mortality in the PNBs group, even though most of these patients are older.

There are recognized limitations to this study. Firstly, this study is retrospective and the use of an administrative database that might be subject to inaccuracies in coding and data collection could have influenced the results of the study. Some "atypical" complications are more prevalent in elderly patients, but the data were not recorded and analyzed. In addition, the database did not allow the authors to assess outcomes with respect to pain and intraoperative parameters. Secondly, the patients' status and anesthesiologists' favorites could have resulted in anesthesia selection bias. Thus, our existing data does not reflect the real mortality. In addition, our exclusion of patients who did not undergo surgery or who received EA might limit the generalizability of our results. Finally, the small sample size and single center study make it difficult to appreciate statistically significant differences between groups.

Conclusion
==========

Our study has shown that mortality and postoperative complications are not statistically significantly different between PNBs and GA among elderly patients who underwent hemiarthroplasty for FNF. Although patients who received PNBs are older, dementia was more frequently found in the GA group. In fact, perioperative comanagement of geriatric patients with hip fractures may be more important than the anesthesia type. Unfortunately, the team of multi-departments' management was not founded in our hospital.
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![Flowchart showing patient enrollment and analysis.\
**Abbreviations:** GA, general anesthesia; PNBs, peripheral nerve blocks.](ppa-8-651Fig1){#f1-ppa-8-651}

###### 

Comparison of the demographics of 217 elderly patients between the GA and PNBs groups

  -----------------------------------------------------------------------------------------------------------------------------------------
                                                                    Total\        GA group\    PNBs group\   *χ*^2^ or 95% CI   *P*-value
                                                                    (n=217)       (n=72)       (n=145)                          
  ----------------------------------------------------------------- ------------- ------------ ------------- ------------------ -----------
  Female[\*](#tfn2-ppa-8-651){ref-type="table-fn"}                  151 (69.6%)   51 (70.8%)   100 (69.0%)   0.08               0.778

  Age (years)[†](#tfn3-ppa-8-651){ref-type="table-fn"}              79.8±6.6      78.8±5.6     80.1±7.0      −3.16 to −0.56     0.169

  Weight (kg)[†](#tfn3-ppa-8-651){ref-type="table-fn"}              58.3±11.4     57.4±9.3     58.8±12.3     −4.60 to 1.86      0.404

  Height (cm)[†](#tfn3-ppa-8-651){ref-type="table-fn"}              162.1±7.5     161.9±7.2    161.2±7.7     −2.49 to 1.80      0.751

  BMI (kg/m^2^)[\*](#tfn2-ppa-8-651){ref-type="table-fn"}           22.1±3.5      21.8±2.8     22.8±3.9      148.26             0.455

  Operation site (left)[\*](#tfn2-ppa-8-651){ref-type="table-fn"}   109 (50.2%)   37 (51.4%)   72 (49.7%)    0.06               0.810

  ASA status[\*](#tfn2-ppa-8-651){ref-type="table-fn"}                                                       2.60               0.273

   2                                                                77 (35.5%)    25 (34.7%)   52 (35.9%)                       

   3                                                                99 (45.6%)    35 (48.6%)   64 (44.1%)                       

   4                                                                41 (18.9%)    12 (16.7%)   29 (20.0%)                       
  -----------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Data are presented as number (percentage), or ratio or mean ± standard deviation;

*χ*^2^, test of independence;

two-tailed Student's *t*-test.

**Abbreviations:** ASA, American Society of Anesthesiologists; BMI, body mass index; CI, confidence interval; GA, general anesthesia; PNBs, peripheral nerve blocks.

###### 

Intraoperative and postoperative data of the 217 subjects in the GA and PNBs groups

  -------------------------------------------------------------------------------------------------------------------------------------------------
                                                                              Total\       GA group\   PNBs group\   *χ^2^* or 95% CI   *P*-value
                                                                              (n=217)      (n=72)      (n=145)                          
  --------------------------------------------------------------------------- ------------ ----------- ------------- ------------------ -----------
  Waiting time to operation (days)[†](#tfn7-ppa-8-651){ref-type="table-fn"}   7.12±4.18    6.83±4.34   7.26±4.11     −1.62 to 0.76      0.478

  PLOS (days)[†](#tfn7-ppa-8-651){ref-type="table-fn"}                        8.87±4.65    9.25±4.32   8.68±4.81     −7.48 to 1.90      0.393

  ICU (frequency)[\*](#tfn6-ppa-8-651){ref-type="table-fn"}                   38 (17.5%)   9 (12.5%)   29 (20%)      1.87               0.171

  Hospital charges (10^3^ RMB)[†](#tfn7-ppa-8-651){ref-type="table-fn"}       27.2±28.0    23.6±15.6   28.9±32.3     −1.32 to 2.30      0.194

  Duration of operation (minutes)[†](#tfn7-ppa-8-651){ref-type="table-fn"}    105.9±32.4   109±32.3    104.3±32.5    −4.50 to 13.91     0.315

  Intraoperative fluid (mL)[†](#tfn7-ppa-8-651){ref-type="table-fn"}          723±230      720±282     723±200       −67.88 to 62.92    0.941

  Blood loss (mL)[†](#tfn7-ppa-8-651){ref-type="table-fn"}                    424±199      429±199     422±197       −49.17 to 63.17    0.806

  Blood transfusion[†](#tfn7-ppa-8-651){ref-type="table-fn"}                                                                            

   Blood plasma (mL)                                                          253±204      220±177     262±219       −100.56 to 16.56   0.159

   Red blood cells (U)                                                        3.91±2.40    3.81±2.14   3.98±2.55     −51.10 to 50.76    0.995
  -------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Data are presented as mean ± standard deviation or median;

*χ^2^*, test of independence;

two-tailed Student's *t*-test.

**Abbreviations:** CI, confidence interval; GA, general anesthesia; ICU, intensive care unit; PLOS, postoperative hospital length of stay; PNBs, peripheral nerve blocks; RMB, renmenbi.

###### 

Preoperative comorbidities, postoperative complications, and mortality of 217 elderly patients in the GA and PNBs groups

  --------------------------------------------------------------------------------------------------------
                                              Total\       GA group\    PNBs group\   *χ^2^*   *P*-value
                                              (n=217)      n=72)        (n=145)                
  ------------------------------------------- ------------ ------------ ------------- -------- -----------
  **Preoperative comorbidities**                                                               

  Cardiovascular diseases                     69 (31.8%)   21 (29.2%)   48 (33.1%)    0.34     0.558

  Myocardial infarction                       18 (8.3%)    4 (5.6%)     14 (9.7%)     1.06     0.303

  Respiratory system diseases                 52 (24.0%)   15 (20.8%)   37 (25.5%)    0.15     0.698

  Diabetes                                    51 (23.5%)   16 (22.2%)   35 (24.1%)    0.10     0.754

  Stroke                                      48 (22.1%)   16 (22.2%)   32 (22.1%)    0.00     0.980

  Dementia                                    33 (15.2%)   19 (26.4%)   14 (9.7%)     10.45    0.001

  Delirium                                    38 (17.5%)   15 (20.8%)   23 (15.9%)    0.82     0.364

  Renal disease                               22 (10.1%)   8 (11.1%)    14 (9.7%)     0.11     0.738

  Electrolyte disturbances                    23 (10.6%)   9 (12.5%)    14 (9.7%)     0.41     0.522

  Hypoxemia                                   33 (15.2%)   13 (18.1%)   20 (13.8%)    0.68     0.410

  Malignancy                                  27 (12.4%)   8 (11.1%)    19 (13.1%)    0.18     0.675

  Number of patients with no comorbidities:   54 (24.9%)   14 (19.4%)   40 (27.6%)    7.26     0.064

   1                                          72 (33.2%)   25 (34.7%)   47 (32.4%)             

   2                                          57 (26.3%)   21 (29.2%)   36 (24.8%)             

   ≥3                                         34 (15.7%)   12 (16.7%)   22 (15.2%)             

  **Postoperative complications**                                                              

  Acute cardiovascular events                 55 (25.3%)   18 (25.0%)   37 (25.5%)    0.01     0.934

  Myocardial infarction                       8 (3.7%)     2 (2.8%)     6 (4.1%)      0.25     0.617

  Acute respiratory events                    33 (15.2%)   13 (18.1%)   20 (13.8%)    0.68     0.410

  Stroke                                      9 (4.1%)     5 (6.9%)     4 (2.8%)      2.12     0.145

  Delirium                                    50 (23.0%)   18 (25.0%)   32 (22.1%)    0.23     0.629

  DVT/PE                                      11 (5.1%)    5 (6.9%)     6 (4.1%)      0.79     0.375

  Renal disorder                              37 (17.1%)   11 (15.3%)   26 (17.9%)    0.24     0.625

  Electrolyte disturbances                    51 (23.5%)   20 (27.8%)   31 (21.4%)    1.10     0.295

  Anemia                                      33 (15.2%)   12 (16.7%)   21 (14.5%)    0.18     0.673

  Hypoxemia                                   42 (19.4%)   19 (26.4%)   23 (15.9%)    3.42     0.065

  Deep wound infection                        20 (9.2%)    7 (9.7%)     13 (9.0%)     0.03     0.856

  Number of complications:                    67 (30.9%)   17 (23.6%)   50 (34.5%)    5.10     0.165

   1                                          68 (31.3%)   23 (31.9%)   45 (31.0%)             

   2                                          51 (23.5%)   17 (23.6%)   34 (23.5%)             

   ≥3                                         31 (14.3%)   15 (20.8%)   16 (11.0%)             

  **Postoperative mortality**                                                                  

  In-hospital                                 15 (6.9%)    7 (9.7%)     8 (5.5%)      1.32     0.250

  30-day                                      32 (14.7%)   12 (16.7%)   20 (13.8%)    0.32     0.574

  1-year                                      51 (23.5%)   16 (22.2%)   35 (24.1%)    0.10     0.886
  --------------------------------------------------------------------------------------------------------

**Notes:** Data are presented as number (percentage), or ratio or mean ± standard deviation. Cardiovascular diseases include hypertension, coronary artery disease, and arrhythmia; respiratory system diseases include chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, pneumonia, and chronic bronchitis; *χ^2^*, test of independence.

**Abbreviations:** DVT/PE, deep vein thrombosis/pulmonary embolus; GA, general anesthesia; PNBs, peripheral nerve blocks.

###### 

Univariate Cox regression analysis of all variables for mortality at 30 days and 1 year postoperatively: final step

                                    30-day mortality                                                  1-year mortaily
  --------------------------------- ----------------------------------------------------------------- ----------------------------------------------------------------
  Male sex                          1.8 (1.6 to 2.5)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}     1.6 (1.2 to 3.2)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}
  ICU admission                     1.8 (1.2 to 3.8)                                                  1.3 (0.8 to 2.0)
  ≥85 years                         2.8 (1.5 to 5.5)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}       3.0 (2.1 to 5.4)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}
  **Preoperative comorbidities**                                                                      
  Cardiovascular diseases           1.7 (1.2 to 2.0)                                                  1.3 (1.1 to 1.8)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}
  Diabetes                          1.2 (0.9 to 1.9)                                                  1.4 (1.1 to 1.7)
  Respiratory system diseases       2.4 (1.4 to 3.8)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}       1.8 (1.2 to 2.8)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}
  Stroke                            1.3 (1.1 to 1.7)                                                  1.1 (0.9 to 1.5)
  Dementia                          2.2 (1.4 to 4.8)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}       2.5 (2.1 to 4.0)
  Hypoxia                           3.6 (1.5 to 12.4)                                                 1.9 (0.8 to 5.2)
  Malignancy                        1.2 (1.0 to 2.0)                                                  1.7 (1.4 to 2.9)
  Comorbidities ≥3                  2.2 (1.5 to 3.2)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}     2.5 (2.2 to 3.7)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}
  ASA ≥ III                         2.5 (1.8 to 4.4)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}     3.8 (2.6 to 5.8)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}
  **Postoperative complications**                                                                     
  Acute cardiovascular events       8.8 (5.0 to 18.9)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}    6.0 (3.2 to 10.6)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}
  Myocardial infarction             10.1 (3.3 to 36.7)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}   8.4 (2.0 to 32.5)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}
  Acute respiratory events          8.5 (6.6 to 13.1)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}    5.0 (3.5 to 7.3)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}
  Stroke                            8.8 (4.9 to 18.5)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}    5.6 (3.4 to 9.7)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}
  Delirium                          2.0 (1.2 to 4.3)                                                  1.6 (0.9 to 3.4)
  DVT/PE                            1.9 (1.1 to 4.2)                                                  2.3 (1.7 to 3.6)
  Hypoxia                           3.6 (1.9 to 8.8)[\*](#tfn13-ppa-8-651){ref-type="table-fn"}       2.4 (1.3 to 4.4)
  Anemia                            0.9 (0.6 to 2.3)                                                  1.6 (0.9 to 2.8)
  Deep wound infection              0.5 (0.1 to 4.8)                                                  1.2 (1.0 to 3.5)
  ≥3 complications                  14.5 (8.9 to 19.9)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}   7.8 (4.6 to 10.3)[\*\*](#tfn12-ppa-8-651){ref-type="table-fn"}

**Notes:** Data are hazard ratios (95% confidence intervals);

*P*\<0.01;

*P*\<0.05.

**Abbreviations:** ASA, American Society of Anesthesiologists; DVT/PE, deep vein thrombosis/pulmonary embolus; ICU, intensive care unit.

###### 

Multivariate Cox regression analysis of variables for 30-day and 1-year mortality

                                    30-day mortality                                                 1-year mortality
  --------------------------------- ---------------------------------------------------------------- ---------------------------------------------------------------
  Male sex                          1.6 (1.2 to 2.1)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}      1.8 (1.5 to 3.8)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}
  ICU admission                     2.0 (1.3 to 4.2)                                                 1.3 (0.9 to 2.4)
  ≥85 years                         1.8 (1.2 to 4.0)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}      2.2 (1.5 to 4.6)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}
  **Preoperative comorbidities**                                                                     
  Cardiovascular diseases           0.9 (0.7 to 1.3)                                                 1.2 (0.9 to 2.1)
  Diabetes                          1.1 (0.8 to 1.7)                                                 1.2 (1.0 to 1.7)
  Respiratory system diseases       2.4 (1.5 to 3.8)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}      1.8 (1.2 to 3.3)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}
  Stroke                            1.2 (0.9 to 1.9)                                                 1.1 (0.9 to 1.6)
  Dementia                          2.0 (1.5 to 3.7)                                                 2.2 (1.8 to 4.0)
  Hypoxia                           2.2 (1.8 to 7.2)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}      1.5 (1.2 to 2.6)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}
  Malignancy                        1.3 (1.1 to 2.5)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}      1.4 (1.1 to 2.8)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}
  **Postoperative complications**                                                                    
  Acute cardiovascular events       5.8 (4.5 to 11.7)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}   4.6 (3.0 to 9.8)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}
  Myocardial infarction             6.2 (2.5 to 9.6)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}    3.8 (2.2 to 6.1)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}
  Acute respiratory events          4.4 (3.2 to 9.0)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}    3.5 (3.0 to 6.8)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}
  Stroke                            2.6 (1.3 to 5.5)[\*\*](#tfn16-ppa-8-651){ref-type="table-fn"}    3.0 (2.3 to 6.2)[\*](#tfn17-ppa-8-651){ref-type="table-fn"}
  Acute renal impairment            1.8 (0.8 to 3.3)                                                 2.0 (1.1 to 3.4)
  Hypoxia                           3.5 (1.9 to 6.4)                                                 1.8 (1.3 to 2.8)

**Notes:** Data are hazard ratios (95% confidence intervals);

*P*\<0.01;

*P*\<0.05.

**Abbreviation:** ICU, intensive care unit.

[^1]: \*These authors contributed equally to this work
